Jumayev M. Yu, Jumayev M. Yu, Xayitova G. A, Xayitova G. A, Xalilova X. A, Xalilova X. A (2026) SUT BEZI SARATONI KASALLIGINI KIMYOTERAPIYA BILAN DAVOLASHNING YUTUQ VA KAMCHILIKLARI. INTERNATIONAL CONFERENCE ON ADVANCE SCIENCE AND TECHNOLOGY, 3 (2). pp. 53-55.
![[thumbnail of 53-55.pdf]](https://arxiv.universalpublishings.com/style/images/fileicons/application_pdf.png)
PDF
53-55.pdf - Published Version
Download (233kB)
Annotatsiya
Sut bezi saratoni (SBS) ayollar orasida eng ko‘p uchraydigan onkologik kasallik bo‘lib, global o‘lim sabablaridan biri hisoblanadi. Kimyoterapiya kasallikning erta va rivojlangan bosqichlarida muhim davolash usuli sifatida qo‘llaniladi. Ayniqsa, antrasiklinlar, taksanlar va platina asosidagi preparatlar adjuvant, neoadjuvant hamda metastatik bosqichlarda samarali hisoblanadi. Ushbu maqolada kimyoterapiyaning klinik samaradorligi, omon qolish ko‘rsatkichlariga ta’siri hamda nojo‘ya ta’sirlari tahlil qilinadi.
| Hujjat turi: | Maqola |
|---|---|
| Mualliflar: | Muallif Email Jumayev M. Yu, Jumayev M. Yu UNSPECIFIED Xayitova G. A, Xayitova G. A UNSPECIFIED Xalilova X. A, Xalilova X. A UNSPECIFIED |
| Jurnal / Nashr: | INTERNATIONAL CONFERENCE ON ADVANCE SCIENCE AND TECHNOLOGY |
| Jild: | 3 |
| Soni: | 2 |
| Sahifalar: | pp. 53-55 |
| Sana: | 29 Mart 2026 |
| Kalit so'zlar: | sut bezi saratoni, kimyoterapiya, doksorubitsin, paklitaksel, neoadjuvant terapiya, toksiklik, umumiy omon qolish. |
| URI: | https://arxiv.universalpublishings.com/id/eprint/95691 |
![[pin missing: title]](/style/images/action_view.png)
- [pin missing: title]